Skip to main content
Back to Variant Registry
PharmacogenomicsEvidence 4Physician review

rs12248560 · CYP2C19

Risk allele: T

Risk-Allele Phenotype

CYP2C19 rs12248560 — associated with increased CYP2C19 enzyme function, leading to enhanced metabolism of clopidogrel to its active form and potentially altered antiplatelet efficacy and bleeding risk.

Reference-Allele Phenotype

Normal CYP2C19 metabolizer function at this locus, associated with standard clopidogrel activation and expected antiplatelet response.

Evidence Level

4Preliminary See methodology for how we grade evidence.

Cross-References

Informational only

This page summarizes population-level evidence about a genetic variant. It is not a diagnosis. Your individual risk depends on your full genome, lifestyle, environment, and family history. Consult a healthcare provider for personalized medical advice.

Want to know your status at rs12248560?

Upload your DNA file — Atlagene checks this variant and 700+ others across 21 health categories.

Get Started Free